Treatment Strategies for Atopic Dermatitis

This activity is designed for dermatologists, pediatricians, pediatric dermatologists, allergists; and physician assistants, nurse practitioners, and nurses in dermatology and allergy actively treating patients with AD.

Supported by educational grants from:

Pfizer Inc. and Sanofi Genzyme and Regeneron Pharmaceuticals

Activity Information


Original Release Date: December 31, 2018
Expiration Date: December 31, 2019
Estimated Time to Complete Activity: .25 hour per activity
Media: Internet



Method of Participation

Participants should read the activity information, review the activity in its entirety, and complete the online post-test and evaluation. Upon completing this activity as designed and achieving a passing score on the post-test, you will be directed to a Web page that will allow you to receive your certificate of credit via e-mail or you may print it out at that time.

Inquiries about CME accreditation may be directed to the Postgraduate Institute for Medicine (PIM) at or (303) 799-1930.

Activity questions may be directed to Global Academy for Medical Education at [email protected] or 973-290-8225.

Joint Provider Statement

In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.


Linda F. Stein Gold, MD
Director of Dermatology Research
Division Head of Dermatology
Henry Ford Health System
Detroit, Michigan

Luz Fonacier, MD
Head of Allergy
Training Program Director
Winthrop University Hospital
Mineola, New York
Professor of Medicine
SUNY Stony Brook
Stony Brook, New York

Moise L. Levy, MD
Professor of Pediatrics and Medicine (Dermatology)
Dell Children’s Medical School
University of Texas, Austin
Clinical Professor of Dermatology and Pediatrics
Baylor College of Medicine
Pediatric/Adolescent Dermatology
Dell Children's Medical Center
Austin, Texas


Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Dr. Stein Gold: Speaker’s Bureau: Allergan, Celgene, Galderma, Leo, Novartis, Pfizer, Valeant; Consultant: AbbVie, Allergan, Celgene, Galderma, Leo, Medimetrix, Novartis, Pfizer, Promius, Valeant; Fees for Non-CME Services Received Directly from a Commercial Interest or Its Agent: AbbVie, Allergan, Celgene, Dermira, Galderma, La Roche Posay, Leo, Medimetrix, Novan, Novartis, Pfizer, Promius, Sebela, Valeant; Contracted Research: Aqua, Allergan, Dermira, Galderma; Leo, Pfizer, Valeant.

Dr. Fonacier: Consultant: Regeneron/Sanofi, Fees for Non-CME Services Received Directly from a Commercial Interest or Its Agent: Regeneron/Sanofi, and Contract Research: Pfizer, Regeneron/Sanofi, and Shire to NYU Winthrop Hospital.
Dr. Levy: Consultant: Castle Creek Pharmaceuticals; Contracted Research: Amicus.

Planners and Managers

The PIM planners and managers have nothing to disclose. The Global Academy for Medical Education planners and managers have nothing to disclose

Learning Objectives

At the conclusion of this program, participants should be better able to:

  • Describe the current theories of the pathophysiology of AD
  • Identify and apply the diagnostic criteria for AD
  • Employ strategies to manage patients with mild-to-moderate and moderate-to-severe AD

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Activity Viewing Requirements

Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets: Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Copyright © 2018 by Global Academy for Medical Education, LLC; and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Global Academy for Medical Education, LLC, will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.